In the tumour microenvironment, overexpression of CD155 suppresses DNAM-1 on NK cells and CD8+ T cells, resulting in NK and CD8+ T-cell inactivation, resulting in uninhibited cancer cell proliferation [32,179,180,197]. This evidence concerns the gene CD226 and cancer.